These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Allergenic products standardization--the role of major allergens. Helm RM, Burks AW. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997 Aug; (91):164-73. PubMed ID: 9383906 [No Abstract] [Full Text] [Related]
10. [Diagnostic and therapeutic value of synthetic or recombinant allergens]. Spertini F. Rev Med Suisse Romande; 1999 Mar; 119(3):235-9. PubMed ID: 10218421 [Abstract] [Full Text] [Related]
11. Recombinant and modified allergens: the U.S. perspective. Rabin RL. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2006 Mar; (95):191-3; discussion 193-4. PubMed ID: 17393739 [Abstract] [Full Text] [Related]
13. Antibody-based methods for standardization of allergoids and recombinant hypoallergens. Fiebig H, Kahlert H, Weber B, Suck R, Nandy A, Cromwell O. Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009 Mar; 96():71-82; discussion 82-3. PubMed ID: 20799447 [No Abstract] [Full Text] [Related]
14. Recombinant allergens for specific immunotherapy. Valenta R, Vrtala S. Allergy; 1999 Mar; 54 Suppl 56():43-4. PubMed ID: 10532305 [No Abstract] [Full Text] [Related]
15. [Recombinant allergens and their potential in allergologic diagnosis]. Crameri R, Blaser K, Menz G. Pneumologie; 1996 Jun; 50(6):387-93. PubMed ID: 8766370 [No Abstract] [Full Text] [Related]
16. Current problems of regulation of allergenic extracts in Germany. Haustein D. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997 Jun; (91):123-6. PubMed ID: 9383900 [No Abstract] [Full Text] [Related]
17. Clinical testing of recombinant allergens of the mold Alternaria alternata. Unger A, Stöger P, Simon-Nobbe B, Susani M, Crameri R, Ebner C, Hintner H, Breitenbach M. Int Arch Allergy Immunol; 1999 Jun; 118(2-4):220-1. PubMed ID: 10224387 [No Abstract] [Full Text] [Related]
18. Recombinant house dust mite allergens. Thomas WR, Smith W, Hales BJ, Carter MD, Bennett BJ, Shen HD, Tovey ER, Chua KY. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997 Jun; (91):87-94; discussion 94-6. PubMed ID: 9383895 [No Abstract] [Full Text] [Related]
19. Synthetic and genetically engineered allergen derivatives for specific immunotherapy of type I allergy. Valenta R, Vrtala S, Focke-Tejkl M, Twardosz A, Swoboda I, Bugajska-Schretter A, Spitzauer S, Kraft D. Clin Allergy Immunol; 2002 Jun; 16():495-517. PubMed ID: 11577556 [No Abstract] [Full Text] [Related]